Skip to main content
. Author manuscript; available in PMC: 2020 Aug 23.
Published in final edited form as: J Neurooncol. 2019 Feb 15;142(3):523–528. doi: 10.1007/s11060-019-03123-0

Table 3.

Multivariate analysis of overall survival

Variable Hazard Ratio (95% CI) P-value

Number of brain metastases
 1 vs 2–5 0.91 (0.19–4.40) 0.90
 1 vs >5 1.36 (0.26–7.08) 0.71

Systemic disease in the lungs
 No vs Yes 1.17 (0.47–2.92) 0.73

Systemic disease in the bone
 No vs Yes 3.01 (1.13–8.02) 0.03

Radiation dose (BED, continuous) 0.93 (0.88–0.98) 0.005

Steroids during radiation
 No vs Yes 1.49 (0.57–3.93) 0.42